Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03580798 |
|
Recruitment Status :
Terminated
(Not enough patients available)
First Posted : July 9, 2018
Last Update Posted : September 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tooth Loss | Procedure: Delayed graft Procedure: Simultaneous graft | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 7 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Ridge Preservation Comparing the Traditional Approach vs. Early Implant Placement With Simultaneous Contour Augmentation |
| Actual Study Start Date : | November 8, 2018 |
| Actual Primary Completion Date : | April 26, 2019 |
| Actual Study Completion Date : | April 26, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Delayed Grafting
8 weeks after extraction implant placement and simultaneous osseous grafting.
|
Procedure: Delayed graft
8 weeks post-extraction 15 test patients will receive implant placement plus osseous grafting. |
|
Active Comparator: Simultaneous Grafting
At the time of extraction the socket will be grafted and implant placed 4 months later.
|
Procedure: Simultaneous graft
At the time of extraction osseous graft will be placed in the socket and implant placed 4 months later. |
- Final ridge width for simultaneous and delayed grafting treatment. [ Time Frame: 16 to 20 weeks ]Measure final ridge width to determine if adequate bone is available.
- Soft tissue thickness [ Time Frame: 16 to 20 weeks ]Facial and occlusal
- Histology [ Time Frame: 16 weeks ]Histologic composition for control group only
- Implant dehiscence [ Time Frame: 20 weeks ]Implant dehiscence
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Have one non-molar maxillary tooth requiring extraction that will be replaced by a dental implant. The site must be bordered by 2 teeth.
- Healthy persons at least 18 years old.
- Patients must sign an informed consent approved by the University of Louisville Human Studies Committee.
Exclusion Criteria:
- Patients with debilitating systemic disease, or diseases that have a clinically significant effect on the periodontium.
- Exclude any molar tooth.
- Presence of or history of osteonecrosis of jaws.
- Patients with current or previous history of IV bisphosphonates, irrespective of duration.
- Patients taking oral bisphosphonates for ≥ 3 years.
- Pregnant women.
- Allergy to any material or medication used in the study.
- Patients who need prophylactic antibiotics prior to dental procedures.
- Previous head and neck radiation therapy.
- Chemotherapy in the previous 12 months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03580798
| United States, Kentucky | |
| Graduate Periodontics, UofL School of Dentistry | |
| Louisville, Kentucky, United States, 40202 | |
| Principal Investigator: | Henry Greenwell, DMD | University of Louisville |
| Responsible Party: | Henry Greenwell, Director of Graduate Peridontics, University of Louisville |
| ClinicalTrials.gov Identifier: | NCT03580798 |
| Other Study ID Numbers: |
18.0348 |
| First Posted: | July 9, 2018 Key Record Dates |
| Last Update Posted: | September 10, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Tooth Loss Periodontal Diseases Mouth Diseases Stomatognathic Diseases Tooth Diseases |

